Carmot Therapeutics Inc. (CRMO)
Carmot Therapeutics was planning to go public, but the IPO was withdrawn on Dec 11, 2023.
Stock Price: Pending
IPO price not available yet

Carmot Therapeutics Statistics

Total Valuation

Market Cap n/a
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio 11.87
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.97

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$876,034
Employee Count 59
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -444,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -67.18M
Pretax Income -52.13M
Net Income -51.69M
EBITDA -45.67M
EBIT -46.32M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has $138.34 million in cash and $4.06 million in debt, giving a net cash position of $134.29 million.

Cash & Cash Equivalents 138.34M
Total Debt 4.06M
Net Cash 134.29M
Net Cash Per Share n/a
Equity (Book Value) -63.71M
Book Value Per Share n/a
Working Capital 131.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$55.73 million and capital expenditures -$1.74 million, giving a free cash flow of -$57.47 million.

Operating Cash Flow -55.73M
Capital Expenditures -1.74M
Free Cash Flow -57.47M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRMO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield n/a
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a